RADNOR, Pa. & GÖTEBORG, Sweden--(BUSINESS WIRE)--Cortendo announced that it will present the study protocol of its global Phase 3 study of COR-003 in patients with endogenous Cushing’s syndrome at ENDO 2015 on March 6, 2015 in San Diego, CA.
| < Prev | Next > |
|---|
